Results of a phase 2 trial of the monocyte-targeted histone deacetylase inhibitor tefinostat (CHR-2845) in chronic myelomonocytic leukemia (CMML) - the UK monocle study - Vyas, P; Hills, R; Knapper, S; Dennis, M; Drummond, M; Dillon, R; Pocock, C; Culligan, D; Wiseman, D; Zabkiewicz, J; Hodges, M; Cargo, C; et al. (American Society of Hematology, 2018)